The multiple roles of tumour stroma

Virchows Archiv

Volumn 430, Issue 6, 1997, Pages 433-443

  Wernert, N ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Roles; Tumour stroma

Indexed keywords

FIBRIN; GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN;

BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; EXTRAVASATION; FIBROBLAST; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; STROMA; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; CAPILLARY PERMEABILITY; CELL DIVISION; EXTRACELLULAR MATRIX; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030843071     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050053     Document Type: Review

References (162)

1. Agrez M, Chen A, Cone R, Pytela R, Sheppard D (1994) The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain. J Cell Biol 127:547-556
2. Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ, Herrlich P (1987) 12-0-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5́ flanking region. Mol Cell Biol 7:2256-2266
3. Autio Harmainen H, Karttunen T, Hurskainen T, Hoyhtya M, Kauppila A, Tryggvason K (1993) Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 69:312-321
4. Bartolazzi A, Cerboni C, Flamini G, Bigotti A, Lauriola L, Natali P (1995) Expression of alpha 3 beta 1 integrin receptor and its ligands in human lung tumors. Int J Cancer 64: 248-252
5. Basset P, Wolf C, Rouyer N, Bellocq JP, Rio MC, Chambon P (1994) Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 74:1045-1049
6. Beissert S, Bergholz M, Waase I, Lepsien G, Schauer A, Pfizenmaier K, Kronke M (1989) Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in-vivo analysis by in-situ hybridization. Proc Natl Acad Sci USA 86:5064-5068
7. Beitz JG, Kim IS, Calabresi P, Frackelton ARJ (1991) Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 88: 2021-2025
8. Bellusci S, Moen G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, Jouanneau J (1994) Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091-1099
9. Blanchi E, Cohen RL, Thor AT, Todd RF, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA, Smith HS (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 15:861-866
10. Bicknell R, Vallee BL (1988) Angiogenin activates endothelial cell phospholipase C. Proc Natl Acad Sci USA 86:5961-5965
11. Birchmeier C, Birchmeier W (1993) Molecular aspects of mesenchymal-epithelial interactions. Annu Rev Cell Biol 9: 511-540
12. Birkenmeier TM, McQuillan JJ, Boedeker ED, Argraves WS, Ruoslahti E, Dean D (1991) The alpha 5 beta 1 fibronectin receptor. Characterization of the alpha 5 gene promoter. J Biol Chem 266:20544-20549
13. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E (1995) Expression of c-Ets 1, collagenase 1 and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147:1298-1310
14. Bonkhoff H, Stein U, Remberger K (1993) Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol 24:243-248
15. 2++ and von Willebrand factor release in human endothelial cells. Am J Pathol 138:213-221
16. Brown LF, Asch B, Harvey VS, Buchinski B, Dvorak HF (1988) Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas. Cancer Res 48:1920-1925
17. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86-91
18. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53:4727-4735
19. Brown LF, Van de Water L, Harvey VS, Dvorak HF (1988) Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. Am J Pathol 130: 455-465
20. Buck CA, Horwitz AF (1987) Cell surface receptors for extracellular matrix molecules. Annu Rev Cell Biol 3:179-205
21. Castronovo V, Colin C, Claysmith AP, Chen PHS, Lifrange E, Lambotte R, Krutzsch H, Liotta LA, Sobel ME (1990) Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am J Pathol 137:1373-1381
22. Chiquet-Ehrismann R (1991) Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol 3:800-804
23. Chung LWK, Li W, Gleave ME, Hsieh JT, Wu HC, Sikes RA, Zhau HE, Bandyk MG, Logothetis CJ, Rubin JS, Von Eschenbach AC (1992) Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem Suppl 16H:99-105
24. Clark E, Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268:233-239
25. Clarke AS, Lotz MM, Chao C, Mercurio AM (1995) Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain. J Biol Chem 270:22673-22676
26. Clavel C, Polette M, Doco M, Binninger I, Birembaut P (1992) Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology. Bull Cancer (Paris) 79:261-270
27. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA (1990) Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87:1323-1327
28. Conolly DT, Oleander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Hymore BL, Leimgruber R, Feder J (1989) Human vascular permeability factor. Isolation from U 937 cells. J Biol Chem 264:20017-20024
29. Cunha GR (1994) Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74:1030-1044
30. Daémi N, Vallet T, Jacquier MF, Rémy L (1994) Laminin, integrins, organisation et comportement invasif des adénocarcinomes. Médicine/Sciences 10:1275-1281
31. Damsky CH, Werb Z (1992) Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 4:772-81
32. Deleted in production
33. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991
34. Dedhar S (1989) Regulation of expression of the cell adhesion receptors integrins by recombinant human interleukin-1β in human osteosarcoma cells. Inhibition of cell proliferation and stimulation of alkaline phosphatase activity. J Cell Physiol 138:291-299
35. Desbiens X, Queva C, Jaffredo T, Stehelin D, Vandenbunder B (1991) The relationship between cell proliferation and the transcription of the nuclear oncogenes c-myc, c-myb and c-ets-1 during feather morphogenesis in the chick embryo. Development 111:699-713
36. Dhom G (1994) Die Krebszelle und das Bindegewebe. Pathologe 15:271-278
37. Dingemans KP, Zeeman-Boeschoten IM, Keep RF, Das PK (1993) Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer 54: 1010-1016
38. Di-Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6:1997-2003
39. Droz D, Patey N, Paraf F, Chretien Y, Gogusev J (1994) Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab Invest 71:710-718
40. Dvorak HF (1986) Tumors: wounds that do not heal. N Engl J Med 315:1650-1659
41. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
42. Dvorak HF, Nagy JA, Berse B, Brown Lf, Yeo KT, Yeo TK, Dvorak AM, Water L van de, Sioussat TM, Senger DR (1992) Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann NY Acad Sci 667: 101-111
43. Erickson HP (1993) Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of junctions. Curr Opin Cell Biol 5:869-876
44. Favard C, Moukadiri H, Dorey C, Praloran V, Plouet J (1991) Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell 73:1-6
45. Feige JJ, Quirin N, Souchelnitskiy S (1996) TGF beta, un peptide biologique sous controle: formes latentes el mecanismes d'activation. Medecine/Science 12:929-939
46. Fett JW, Strydom DS, Lobb RR, Bethune JL, Alderman EM, Riordan JF, Vallee BL (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480-5486
47. Flaumenhaft R, Moscatelli D, Rifkin DB (1990) Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 111:1651-1659
48. Flaumenhaft R, Rifkin DB (1992) The extracellular regulation of growth factor action. Mol Biol Cell 3:1057-1065
49. Folkman J (1985) Towards an understanding of angiogenesis: search and discovery. Perspect Biol Med 29:10-36
50. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid, and other diseases. Nat Med 1:27-31
51. Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442-447
52. Frater-Schroder M, Risau W, Hallman R, Gautschi PB (1987) Tumor necrosis factor type-alpha, a potent inhibitor of endothelial cell growth in-vitro, is angiogenic in-vivo. Proc Natl Acad Sci USA 84:5277-5281
53. Gabbert H (1985) Mecanisms of tumor invasion: evidence from in-vivo observations. Cancer Metastasis Rev 3:257-279
54. Galmiche A, Lustenberger P (1994) CD 44, invasion tumorale et métastase. Médicine/Science 10:1282-1291
55. Garrone R, Exposito J, Franc J, Franc S, Humbert-David N, Qint L, Tillet E (1993) La phylogénèse de la matrice extracellulaire. C R Seances Soc Biol Fil 187:114-123
56. Gavrilovic J, Moens G, Thiery JP, Jouanneau J (1990) Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul 1:1003-1014
57. Gilles F, Raes MB, Stéhelin D, Vandenbunder B, Fafeur V (1996) The c-ets-1 proto-oncogene is a new early response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp Cell Res 222:370-378
58. Gohring UJ, Ingenhorst A, Crombach G, Scharl A (1993) Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results. Pathologe 14:3313-3317
59. Gray ST, Yun K, Motoori T, Kuys YM (1993) Interstitial collagenase gene expression in colonic neoplasia. Am J Pathol 143:663-671
60. Gregoire M, Lieubeau B (1995) The role of fibroblasts in tumor behaviour. Cancer Metastasis Rev 14:339-350
61. Grevin D, Chen JH, Raes MB, Stehelin D, Vandenbunder B, Desbiens X (1993) Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation. Int J Dev Biol 37:519-529
62. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
63. Gutman A, Wasylyk B (1990) The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246
64. Hall PA, Coates P, Lemoine NR, Horton MA (1991) Characterization of integrin chains in normal and neoplastic human pancreas. J Pathol 165:33-41
65. Hauptmann S, Denkert C, Lohrke H, Tietze L, Ott S, Klosterhalten B, Mittermayer C (1995) Integrin expression on colorectal tumor cells growing as monolayers, as multicellular tumor spheroids, or in nude mice. Int J Cancer 61:819-825
66. Herrlich P, Pals S, Ponta H (1995) CD44 in colon cancer. Eur J Cancer: 1110-1112
67. Herrmann JL, Chen JH, Nakajima M, Nicholson GA (1993) A c-ets-1 protooncoprotein binding site in the 72-kDa type IV collagenase promoter of human metastatic melanoma cells. Clin Exp Metastasis 10:94
68. Hoffman S, Dutton SI, Ernst H, Boackle MK, Everman D, Tourkin A, Loike JD (1994) Functional characterization of antiadhesion molecules. Perspect Dev Neurobiol 2:101-110
69. Holmgren L, Glaser A, Pfeifer-Ohlsson S, Ohlsson R (1991) Angiogenesis during human extraembryonic development involves the spatio-temporal control of PDGF ligand and receptor gene expression. Development 113:749-754
70. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51:6180-6184
71. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailibility by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037
72. Hynes RO (1987) Integrins: a family of cell surface receptors. Cell. 48:549-554
73. Hynes RO (1992) Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69:11-25
74. Iozzo RV (1995) Tumor stroma as a regulator of neoplastic behaviour. Lab Invest 73:157-160
75. Ishihara A, Yatani R, Sakakura T (1993) Relationship of an extracellular matrix protein, tenascin and breast diseases. Rinsho Byori 41:1099-1107
76. Jiang WG, Lloyds D, Puntis MC, Nakamura T, Hallett MB (1993) Regulation of spreading and growth of colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis 11: 235-242
77. Jouanneau J, Gavrilovic J, Caruelle D, Jaye M, Moens G, Caruelle JP, Thiery JP (1991) Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc Natl Acad Sci USA 88:2893-2897
78. Juliano RL, Haskill S (1993) Signal transduction from the extracellular matrix. J Cell Biol 120:577-585
79. Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrthonen S, Alitalo K (1994) Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 54:6571-6577
80. Kallianpur AR, Jordan JE, Brandt SJ (1994) The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83: 1200-1208
81. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104
82. Kawahara E, Ooi A, Nakanishi I (1995) Integrin distribution in gastric carcinoma: association of beta 3 and beta 5 integrins with tumor invasiveness. Pathol Int 45:493-500
83. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in-vivo. Nature 362:841-844
84. Koretz K, Schlag P, Boumsell L, Möller P (1991) Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol 138:741-750
85. Koukoulis GK, Virtanen I, Korhohnen M, Laitinen L, Quaranta V, Gould V (1991) Immunohistochemical localization of integrins in the normal, hyperplastic and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. Am J Pathol 139:787-799
86. La Rocca SA, Grossi M, Falcone G, Alema S, Tato F (1989) Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells. Cell 58: 123-131
87. Laiho M, Saksela O, Andreasen PA, Keski-Oja J (1986) Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor beta. J Cell Biol 103:2403
88. Laudet V, Niel C, Duterque-Coquillaud M, Leprince D, Stehelin D (1993) Evolution of the ets gene family. Biochem Biophys Res Commun 190:8-14
89. Lehmann M, Rabenandrasana C, Tamura R, Lissitzky J, Quaranta V, Pichon J, Marvaldi J (1994) A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6. Cancer Res 54: 2102-2107
90. Leprince D, Gégonne A, Coll J, Taisne C, Schneeberger A, Lagrou C, Stéhelin D (1983) A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306:395-397
91. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
92. Macleod K, Leprince D, Stéhelin D (1992) The ets gene family. Trends Biochem Sci 17:251-256
93. Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455-463
94. Matsumoto K, Matsumoto K, Nakamura T, Kramer RH (1994) Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269:31807-31813
95. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in-vivo by a dominant-negative Flk-1 mutant. nature 367:576-579
96. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller N, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846
97. Moses HL, Yang EJ, Pietenpol JA (1990) TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247
98. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato JD (1991) Vascular endothelial cell growth factor (VEGF) produced by A 431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci USA 88:5819-5823
99. Nerlov C, Rorth P, Blasi F, Johnsen M (1991) Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592
100. Nicolson GL (1982) Cancer metastasis. Organ colonization and the cell surface properties of malignant cells. Biochim Biophys Acta 695:113-176
101. 100a. Nies DE, Hemesath TJ, Kim JH, Gulcher JR, Stefansson K (1991) The complete cDNA Sequence of human hexabrachion (tenascin). A multidomain protein containing unique epidermal growth factor repeats. J Biol Chem 266:2818-2823
102. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P (1995) Membrane-type matrix metalloproteinse (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 28:2730-2734
103. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328
104. Overall CM, Wrana JL, Sodek J (1991) Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266:14064-14071
105. Parsons JT (1996) Integrin-mediated signaling: regulation by protein tyrosine kinases and small GTP-binding proteins. Curr Opin Cell Biol 8:146-152
106. Pentel M, Helm K, Maloney M (1995) Cell surface molecules in basal cell carcinomas. Dermatol Surg 10:858-861
107. Peters KG, Werner S, Chen G, Williams LT (1992) Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114:233-243
108. Pignatelli M, Handby AM, Stamp GWH (1991) Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours. J Pathol 165:25-32
109. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in-vivo regulatory mechanisms. Int J Cancer 59:520-529
110. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
111. Ponta H, Sleeman J, Dall P, Moll J, Sherman L, Herrlich P (1994) CD44 isoforms in metastatic cancer. Invasion Metastasis 14:82-86
112. Prieto AL, Edelman GM, Crossin KL (1993) Multiple integrins mediate cell attachment to cytotactin-/tenascin. Proc Natl Acad Sci USA 90:10154-10158
113. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dano K (1991) The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the stroma. Cancer Res 51:4067-4071
114. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K (1991) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138:1059-1067
115. r 72000 and 92000 type IV collagenases in human skin cancers by in-situ hybridization. Cancer Res 52:1336-1341
116. Pyke C, Ralfkiær E, Tryggvason K, Danø K (1993) Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142:359-365
117. Rak JW, St. Croix BD, Kerbel RS (1995) Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 6:3-18
118. Reilly CF, McFall RC (1991) Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem 266:9419-9427
119. Rorth P, Nerlov C, Blasi F, Johnsen M (1990) Transcription factor PEA3 participates in the induction of urokinuse plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res 18:5009-5017
120. Rossino P, Gavazzi I, Timpl R, Aumalliey M, Abbadini M, Giancotti F, Silengo L, Marchisio PC, Tarone G (1990) Nerve growth factor induces increased expression of a luminin-binding integrin in rat pheochromocytoma PC12 cells. Exp Cell Res 189:100-108
121. Rubin LL (1992) Endothelial cells: adhesion and tight junctions. Curr Opin Cell Biol 4:830-833
122. Ruoslahti E, Yamaguchi Y (1991) Proteoglycans as modulators of growth factor activities. Cell 64:867-869
123. Sappino AP, Schürch W, Gabbiani G (1990) Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63: 144-161
124. Sato H, Seiki M (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405
125. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65
126. Schmitt M, Janicke F, Moniwa N, Chucholowski N, Pache L, Graeff H (1992) Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol Chem Hoppe Seyler 373:611-622
127. Schor SL, Schor AM (1987) Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. Bioessays 7:200-204
128. Schubert D, Kimura H (1991) Substratum-growth factor collaborations are required for the mitogenic activities of activin and FGF on embyonal carcinoma cells. J Cell Biol 114: 841-846
129. Schwartz MA (1992) Transmembrane signaling by integrins. Trends Cell Biol 2:304-308
130. Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zoller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443-455
131. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774-1778
132. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
133. Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632
134. Seslar S, Nakamura T, Byers S (1995) Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-beta activation. Endocrinology 136:1945-1953
135. Sherman L, Sleeman J, Herrlich P, Ponta H (1994) Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6:726-733
136. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
137. Sleeman J, Moll J, Sherman L, Dall P, Pals ST, Ponta H, Herrlich P (1995) The role of CD44 splice variants in human metastatic cancer. Ciba Found Symp 189:142-151
138. Song Z, Varani J, Goldstein I (1995) Expression and function of beta 1 integrins on adherent and nonadherent Ehrlich ascites tumor cells. Exp Cell Res 218:96-104
139. Stoker M, Pennyman M (1986) An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77:209-224
140. Takehara K, LeRoy EC, Grotendorst GR (1987) TGFb inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth regulatory (competence) gene expression. Cell 415-422
141. Takeyama H, Wakamya N, O'Hara C, Arthur K, Nilloff J, Kufe D, Sakarai K, Spriggs D (1991) Tumor necrosis factor expression by human ovarian carcinoma in-vivo. Cancer Res 51:4476-4480
142. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR typrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586
143. Thiery JP, Boyer B (1992) The junction between cytokines and cell adhesion. Curr Opin Cell Biol 4:782-792
144. Thomas L, Byers HR, Vink J, Stamenkovic I (1992) CD 44 H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118:971-977
145. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954
146. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, Stéhelin D (1989) Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood forming system of the chick embryo. Development 107:265-274
147. Vassalli JD, Pepper MS (1994) Membrane proteases in focus. Nature 370:14-15
148. Vlodavsky I, Bar-Shavit R, Ishai-Michaelj R, Bashkin P, Fuks Z (1991) Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 16:268-271
149. Warn R (1994) A scattering of factors. Curr Biol 4:1043-1045
150. Wasylyk C, Gutman A, Nicholson R, Wasylyk B (1991) The c-ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10:1127-1134
151. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunden B, Stéhelin D (1994) Stromal Expression of c-Ets 1 transcription factor correlates with tumor invasion. Cancer Res 54:5683-5688
152. Wernert N, Raes MB, Lasalle P, Gosselin B, Vandenbunder B, Stéhelin D (1992) The c-ets 1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in man. Am J Pathol 140:119-127
153. Wielenga VJ, Heider KH, Offerhaus GF, Adolf GR, Berg FM van den, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756
154. Wolf C, Chenard MP, Degrossouvre PD, Bellocq JP, Chembon P, Basset P (1992) Breast-cancer associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 99:870-872
155. Wolf C, Levebvre O, Rouyer N, Chenard MP, Bellocq JP, Rio MC, Chambon P, Basset P (1994) Protéases d' origine stromale et progression tumorale. Medicine/Sciences 10:507-515
156. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, Basset P (1993) Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90:1843-1847
157. Yang EY, Moses HL (1990) Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731-741
158. Yayon A, Klagsbrun M, Esko JD, Leder P, Omitz DM (1991) Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848
159. Yokosaki Y, Palmer EL, Prieto AL, Crossin KL, Bourdon MA, Pytela R, Sheppard D (1994) The integrin α9 β1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. J Biol Chem 269:26691-26696
160. Yoshinaga Y, Matsuno Y, Fujita S, Nakamura T, Kikuchi M, Shimosato Y, Hirohashi S (1993) Immunohistochemical detection of hepatocyte growth factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 84:1150-1158
161. Zeromski J, Lawniczak M, Mizera-Nyczak E, Zocchi M (1995) Extracellular matrix proteins and VLA integrins expression in the microenvironment of human lung carcinoma. Pol J Pathol 46:63-69
162. Zutter MM, Mazoujian G, Santoro SA (1990) Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 137:863-870